Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients.

SCOPE Urolithins are bioactive metabolites produced by the gut microbiota from ellagitannins (ETs) and ellagic acid (EA). We investigated whether urolithins could be detected in colon tissues from colorectal cancer (CRC) patients after pomegranate extract (PE) intake. METHODS AND RESULTS CRC patients (n = 52) were divided into controls and PEs consumers (900 mg/day for 15 days) before surgical resection. PEs with low (PE-1) and high (PE-2) punicalagin:EA ratio were administered. Twenty-three metabolites, but no ellagitannins, were detected in urine, plasma, normal (NT) or malignant (MT) colon tissues using UPLC-ESI-QTOF-MS/MS (UPLC, ultra performance liquid chromatography; QTOF, quadrupole TOF). Free EA, five EA conjugates, gallic acid and 12 urolithin derivatives were found in colon tissues. Individual and total metabolites levels were higher in NT than in MT, independently of the PE consumed. The maximal mean concentration (1671 ± 367 ng/g) was found in NT after consumption of PE-1 and the lowest concentration (42.4 ± 10.2 ng/g) in MT with PE-2. Urolithin A or isourolithin A were the main urolithins produced (54 and 46% patients with urolithin A or isourolithin A phenotype, respectively). High punicalagin content (PE-2) hampered urolithins formation. CONCLUSION Significant levels of EA derivatives and urolithins are found in human colon tissues from CRC patients after consumption of pomegranate. Further studies are warranted to elucidate their biological activity.

[1]  J. Espín,et al.  Time course production of urolithins from ellagic acid by human gut microbiota. , 2013, Journal of agricultural and food chemistry.

[2]  J. Espín,et al.  The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP). , 2013, Journal of agricultural and food chemistry.

[3]  Mar Larrosa,et al.  Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. , 2006, Journal of agricultural and food chemistry.

[4]  Liya Li,et al.  Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling. , 2010, Journal of agricultural and food chemistry.

[5]  N. Colburn,et al.  Interleukin-6 as a Potential Indicator for Prevention of High-Risk Adenoma Recurrence by Dietary Flavonols in the Polyp Prevention Trial , 2010, Cancer Prevention Research.

[6]  O. Shaker,et al.  Inhibitory Effect of a Standardized Pomegranate Fruit Extract on Wnt Signalling in 1, 2-Dimethylhydrazine Induced Rat Colon Carcinogenesis , 2013, Digestive Diseases and Sciences.

[7]  M. Garcia-Conesa,et al.  Ellagitannins, ellagic acid and vascular health. , 2010, Molecular aspects of medicine.

[8]  M. Barker,et al.  Effects of Pomegranate Juice Supplementation on Pulse Wave Velocity and Blood Pressure in Healthy Young and Middle-aged Men and Women , 2012, Plant Foods for Human Nutrition.

[9]  C. Hsieh,et al.  The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy. , 2011, Molecular pharmaceutics.

[10]  B. Cerdá,et al.  Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. , 2007, Journal of agricultural and food chemistry.

[11]  Donald J L Jones,et al.  Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration—A Clinical Pilot Study Including Assessment of Patient Acceptability , 2012, Cancer Prevention Research.

[12]  V. Adhami,et al.  Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model. , 2012, Carcinogenesis.

[13]  T. Jess,et al.  Has the risk of colorectal cancer in inflammatory bowel disease decreased? , 2013, World journal of gastroenterology.

[14]  Yukio Sugimoto,et al.  In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A. , 2011, Bioorganic & medicinal chemistry letters.

[15]  Piero Dolara,et al.  Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. , 2010, The Journal of nutritional biochemistry.

[16]  S. Mertens-Talcott,et al.  Pomegranate polyphenolics suppressed azoxymethane-induced colorectal aberrant crypt foci and inflammation: possible role of miR-126/VCAM-1 and miR-126/PI3K/AKT/mTOR. , 2013, Carcinogenesis.

[17]  R. Coppari,et al.  Central administration of resveratrol improves diet-induced diabetes. , 2009, Endocrinology.

[18]  M. Carducci,et al.  A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer , 2012, Prostate Cancer and Prostatic Diseases.

[19]  H. Colom,et al.  The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters. , 2012, Archives of biochemistry and biophysics.

[20]  S. Sela,et al.  One year of pomegranate juice intake decreases oxidative stress, inflammation, and incidence of infections in hemodialysis patients: a randomized placebo-controlled trial. , 2012, Free radical biology & medicine.

[21]  M. Jaakkola,et al.  Urolithins display both antioxidant and pro-oxidant activities depending on assay system and conditions. , 2013, Journal of agricultural and food chemistry.

[22]  R. Elashoff,et al.  Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer , 2006, Clinical Cancer Research.

[23]  M. Garcia-Conesa,et al.  Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. , 2009, Molecular nutrition & food research.

[24]  M. Garcia-Conesa,et al.  Metabolites and tissue distribution of resveratrol in the pig. , 2011, Molecular nutrition & food research.

[25]  R. Benya,et al.  Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia , 2011, Cancer Prevention Research.

[26]  Hanlin L. Wang,et al.  Colorectal carcinoma: Pathologic aspects. , 2012, Journal of gastrointestinal oncology.

[27]  B. Cerdá,et al.  The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy–6H–dibenzopyran–6– one derivatives by the colonic microflora of healthy humans , 2004, European journal of nutrition.

[28]  C. Calhau,et al.  The Bioactivity of Pomegranate: Impact on Health and Disease , 2011, Critical reviews in food science and nutrition.

[29]  Y. Braun-Moscovici,et al.  Consumption of pomegranate decreases serum oxidative stress and reduces disease activity in patients with active rheumatoid arthritis: a pilot study. , 2011, The Israel Medical Association journal : IMAJ.

[30]  M. Garcia-Conesa,et al.  Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells. , 2012, Molecular nutrition & food research.

[31]  S. Feinstein,et al.  Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. , 2009, The American journal of cardiology.

[32]  Mar Larrosa,et al.  Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So Far , 2013, Evidence-based complementary and alternative medicine : eCAM.

[33]  S. Percival,et al.  Fabrication of nanoparticles using partially purified pomegranate ellagitannins and gelatin and their apoptotic effects. , 2011, Molecular nutrition & food research.

[34]  M. Garcia-Conesa,et al.  Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. , 2010, Molecular nutrition & food research.

[35]  K. Spanaus,et al.  Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer - Results of a Phase IIb Randomized Controlled Trial , 2013, Journal of Cancer.

[36]  Donald J L Jones,et al.  Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. , 2010, Cancer research.

[37]  M. Garcia-Conesa,et al.  Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1. , 2009, Journal of agricultural and food chemistry.

[38]  Mar Larrosa,et al.  Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans. , 2012, Journal of agricultural and food chemistry.

[39]  J. Espín,et al.  NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. , 2010, The British journal of nutrition.

[40]  B. Cerdá,et al.  Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. , 2005, Journal of agricultural and food chemistry.